147 related articles for article (PubMed ID: 20586143)
21. Protective value of a folkloric medicinal plant extract against mortality and hemorrhage in a life-threatening renal trauma model.
Tokgöz H; Karakaya K; Hanci V; Abduşoğlu M; Erol B; Türksoy O; Akduman B; Mungan NA
Urology; 2010 Jun; 75(6):1515.e9-14. PubMed ID: 20223504
[TBL] [Abstract][Full Text] [Related]
22. The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding.
Koyuncu N
Adv Ther; 2019 May; 36(5):1143-1149. PubMed ID: 30900196
[TBL] [Abstract][Full Text] [Related]
23. Medicinal plant extract (Ankaferd Blood Stopper) application in deep tissue injuries in rats: histopathological investigation of the effect on regional and systemic tissues.
Okumuş M; Yüksel KZ; Özbağ D; Çıralık H; Yılmaz Z; Gümüşalan Y; Bakan V; Kalender AM
Ulus Travma Acil Cerrahi Derg; 2013 Jan; 19(1):1-7. PubMed ID: 23588971
[TBL] [Abstract][Full Text] [Related]
24. Hemostasis vs. epidural fibrosis?: A comparative study on an experimental rat model of laminectomy.
Erdogan H; Kelten B; Tuncdemir M; Erturkuner SP; Uzun H; Karaoglan A
Neurol Neurochir Pol; 2016; 50(5):323-30. PubMed ID: 27591056
[TBL] [Abstract][Full Text] [Related]
25. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin.
Cipil HS; Kosar A; Kaya A; Uz B; Haznedaroglu IC; Goker H; Ozdemir O; Koroglu M; Kirazli S; Firat HC
Clin Appl Thromb Hemost; 2009; 15(3):270-6. PubMed ID: 19117967
[TBL] [Abstract][Full Text] [Related]
26. Haemostatic role and histopathological effects of a new haemostatic agent in a rat bladder haemorrhage model: an experimental trial.
Kilic O; Gonen M; Acar K; Yurdakul T; Avunduk MC; Esen HH; Oz M
BJU Int; 2010 Jun; 105(12):1722-5. PubMed ID: 19849692
[TBL] [Abstract][Full Text] [Related]
27. Histopathological evaluation of Ankaferd blood stopper use in the rabbit septoplasty model.
Orhan I; Dogan R; Soylu E; Aksoy F; Veyseller B; Ozturan O; Esrefoglu M; Aydın MS
Int J Pediatr Otorhinolaryngol; 2015 Mar; 79(3):305-9. PubMed ID: 25596649
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a haemostatic agent in rabbits.
Turhan N; Bilgili H; Captug O; Kurt M; Shorbagi A; Beyazit Y; Kurt OK; Kosar A; Haznedaroglu IC
Afr J Tradit Complement Altern Med; 2011; 8(1):61-5. PubMed ID: 22238484
[TBL] [Abstract][Full Text] [Related]
29. Bleeding due to slippage of elastic band during variceal ligation: successful use of Ankaferd blood stopper.
Ozaslan E; Purnak T; Yildiz A; Haznedaroglu IC
Indian J Gastroenterol; 2010 Jul; 29(4):166-8. PubMed ID: 20814774
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of hemostatic effects of Ankaferd as an alternative medicine.
Beyazit Y; Kurt M; Kekilli M; Goker H; Haznedaroglu IC
Altern Med Rev; 2010 Dec; 15(4):329-36. PubMed ID: 21194248
[TBL] [Abstract][Full Text] [Related]
31. Effect of Ankaferd Blood Stopper on Skin Superoxide Dismutase and Catalase Activities in Warfarin-Treated Rats.
Aktop S; Emekli-Alturfan E; Gönül O; Göçmen G; Garip H; Yarat A; Göker K
Clin Appl Thromb Hemost; 2017 Mar; 23(2):168-174. PubMed ID: 26354714
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Ankaferd Blood Stopper on bone healing in diabetic rats: a stereological and histopathological study.
Bulut E; Baş B; Altunkaynak BZ; Bekçioğlu B; Erdem Koç G; Gönülol E; Önger ME; Kaplan S
Biotech Histochem; 2014 Oct; 89(7):535-43. PubMed ID: 24799094
[TBL] [Abstract][Full Text] [Related]
33. New coagulant agent (ankaferd blood stopper) for open hemorrhages in hemophilia with inhibitor.
Öner AF; Doğan M; Kaya A; Sal E; Bektaş MS; Yesilmen O; Ayhan H; Acikgoz M
Clin Appl Thromb Hemost; 2010 Dec; 16(6):705-7. PubMed ID: 19528064
[TBL] [Abstract][Full Text] [Related]
34. [Experimental study on hemostasis of thermosensitive chitosan hemostatic film].
Yin G; Wei C; Guo X; Chen H; Hou C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 May; 27(5):624-7. PubMed ID: 23879105
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous ankaferd injection to in vivo liver tissue in comparison to ethanol in an experimental rat model.
Taş A; Köklü S; Beyazit Y; Karaca G; Astarcı HM; Akbal E; Koçak E; Topçu G; Haznedaroglu IC
Clin Res Hepatol Gastroenterol; 2011 Sep; 35(8-9):549-53. PubMed ID: 21489900
[TBL] [Abstract][Full Text] [Related]
36. Comparison of hemostatic efficacy of topical Ankaferd Blood Stopper on heparinized and nonheparinized rats in bleeding related to liver injury.
Ergin M; Özer N
Acta Cir Bras; 2021; 36(1):e360106. PubMed ID: 33533829
[TBL] [Abstract][Full Text] [Related]
37. Intraarticular Ankaferd blood stopper application increases cartilagedegeneration: an experimental study.
Kaya İ; Gülabi D; Yilmaz M; Baş A; Çeçen GS; Şener N
Turk J Med Sci; 2016 Jan; 46(1):236-40. PubMed ID: 27511359
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effects of Ankaferd Blood Stopper on caustic esophageal injuries: an experimental model.
Akbal E; Köklü S; Karaca G; Astarci HM; Koçak E; Taş A; Beyazit Y; Topcu G; Haznedaroğlu IC
Dis Esophagus; 2012 Apr; 25(3):188-94. PubMed ID: 21819483
[TBL] [Abstract][Full Text] [Related]
39. Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures.
Kurt M; Onal I; Akdogan M; Kekilli M; Arhan M; Sayilir A; Oztas E; Haznedaroglu I
Can J Gastroenterol; 2010 Jun; 24(6):380-4. PubMed ID: 20559581
[TBL] [Abstract][Full Text] [Related]
40. Use of Ankaferd Blood Stopper as a hemostatic agent: a clinical experience.
Baykul T; Alanoglu EG; Kocer G
J Contemp Dent Pract; 2010 Jan; 11(1):E088-94. PubMed ID: 20098971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
